192 related articles for article (PubMed ID: 8144662)
1. Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation.
Sasaoka T; Draznin B; Leitner JW; Langlois WJ; Olefsky JM
J Biol Chem; 1994 Apr; 269(14):10734-8. PubMed ID: 8144662
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
[TBL] [Abstract][Full Text] [Related]
3. A mutant insulin receptor induces formation of a Shc-growth factor receptor bound protein 2 (Grb2) complex and p21ras-GTP without detectable interaction of insulin receptor substrate 1 (IRS1) with Grb2. Evidence for IRS1-independent p21ras-GTP formation.
Ouwens DM; van der Zon GC; Pronk GJ; Bos JL; Möller W; Cheatham B; Kahn CR; Maassen JA
J Biol Chem; 1994 Dec; 269(52):33116-22. PubMed ID: 7806540
[TBL] [Abstract][Full Text] [Related]
4. Functional importance of Shc tyrosine 317 on insulin signaling in Rat1 fibroblasts expressing insulin receptors.
Ishihara H; Sasaoka T; Ishiki M; Takata Y; Imamura T; Usui I; Langlois WJ; Sawa T; Kobayashi M
J Biol Chem; 1997 Apr; 272(14):9581-6. PubMed ID: 9083103
[TBL] [Abstract][Full Text] [Related]
5. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
Kim B; Cheng HL; Margolis B; Feldman EL
J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
[TBL] [Abstract][Full Text] [Related]
6. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras.
Pronk GJ; de Vries-Smits AM; Buday L; Downward J; Maassen JA; Medema RH; Bos JL
Mol Cell Biol; 1994 Mar; 14(3):1575-81. PubMed ID: 8114695
[TBL] [Abstract][Full Text] [Related]
8. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
[TBL] [Abstract][Full Text] [Related]
9. Different pathways of postreceptor desensitization following chronic insulin treatment and in cells overexpressing constitutively active insulin receptors.
Inoue G; Cheatham B; Kahn CR
J Biol Chem; 1996 Nov; 271(45):28206-11. PubMed ID: 8910437
[TBL] [Abstract][Full Text] [Related]
10. Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin.
Pruett W; Yuan Y; Rose E; Batzer AG; Harada N; Skolnik EY
Mol Cell Biol; 1995 Mar; 15(3):1778-85. PubMed ID: 7862167
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
Thirone AC; Carvalho CR; Saad MJ
Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
[TBL] [Abstract][Full Text] [Related]
12. Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase.
Foschi M; Chari S; Dunn MJ; Sorokin A
EMBO J; 1997 Nov; 16(21):6439-51. PubMed ID: 9351826
[TBL] [Abstract][Full Text] [Related]
13. The signaling pathway coupling epidermal growth factor receptors to activation of p21ras.
Sasaoka T; Langlois WJ; Leitner JW; Draznin B; Olefsky JM
J Biol Chem; 1994 Dec; 269(51):32621-5. PubMed ID: 7798267
[TBL] [Abstract][Full Text] [Related]
14. CD16-mediated p21ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells.
Galandrini R; Palmieri G; Piccoli M; Frati L; Santoni A
J Exp Med; 1996 Jan; 183(1):179-86. PubMed ID: 8551221
[TBL] [Abstract][Full Text] [Related]
15. Insulin signals to prenyltransferases via the Shc branch of intracellular signaling.
Goalstone ML; Leitner JW; Berhanu P; Sharma PM; Olefsky JM; Draznin B
J Biol Chem; 2001 Apr; 276(16):12805-12. PubMed ID: 11278505
[TBL] [Abstract][Full Text] [Related]
16. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.
Skolnik EY; Lee CH; Batzer A; Vicentini LM; Zhou M; Daly R; Myers MJ; Backer JM; Ullrich A; White MF
EMBO J; 1993 May; 12(5):1929-36. PubMed ID: 8491186
[TBL] [Abstract][Full Text] [Related]
17. Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation.
Welham MJ; Duronio V; Leslie KB; Bowtell D; Schrader JW
J Biol Chem; 1994 Aug; 269(33):21165-76. PubMed ID: 8063737
[TBL] [Abstract][Full Text] [Related]
18. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Shc with Grb2 regulates association of Grb2 with mSOS.
Ravichandran KS; Lorenz U; Shoelson SE; Burakoff SJ
Mol Cell Biol; 1995 Feb; 15(2):593-600. PubMed ID: 7529871
[TBL] [Abstract][Full Text] [Related]
20. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model.
Weng LP; Smith WM; Brown JL; Eng C
Hum Mol Genet; 2001 Mar; 10(6):605-16. PubMed ID: 11230180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
